Royal Bank of Canada’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $351M | Sell |
|
|||||
|
2025
Q1 | $378M | Sell |
|
|||||
|
2024
Q4 | $470M | Sell |
|
|||||
|
2024
Q3 | $715M | Buy |
|
|||||
|
2024
Q2 | $842M | Buy |
|
|||||
|
2024
Q1 | $706M | Buy |
|
|||||
|
2023
Q4 | $390M | Buy |
|
|||||
|
2023
Q3 | $331M | Buy |
|
|||||
|
2023
Q2 | $263M | Buy |
|
|||||
|
2023
Q1 | $252M | Sell |
|
|||||
|
2022
Q4 | $235M | Buy |
|
|||||
|
2022
Q3 | $172M | Sell |
|
|||||
|
2022
Q2 | $204M | Buy |
|
|||||
|
2022
Q1 | $202M | Buy |
|
|||||
|
2021
Q4 | $201M | Buy |
|
|||||
|
2021
Q3 | $163M | Buy |
|
|||||
|
2021
Q2 | $137M | Buy |
|
|||||
|
2021
Q1 | $106M | Buy |
|
|||||
|
2020
Q4 | $103M | Buy |
|
|||||
|
2020
Q3 | $98.2M | Sell |
|
|||||
|
2020
Q2 | $93.1M | Buy |
|
|||||
|
2020
Q1 | $82.5M | Sell |
|
|||||
|
2019
Q4 | $85.7M | Sell |
|
|||||
|
2019
Q3 | $81.5M | Buy |
|
|||||
|
2019
Q2 | $78M | Sell |
|
|||||
|
2019
Q1 | $83.1M | Buy |
|
|||||
|
2018
Q4 | $70.4M | Buy |
|
|||||
|
2018
Q3 | $70.4M | Buy |
|
|||||
|
2018
Q2 | $59.1M | Buy |
|
|||||
|
2018
Q1 | $58.7M | Buy |
|
|||||
|
2017
Q4 | $61.8M | Buy |
|
|||||
|
2017
Q3 | $51.7M | Sell |
|
|||||
|
2017
Q2 | $49.4M | Buy |
|
|||||
|
2017
Q1 | $38.6M | Buy |
|
|||||
|
2016
Q4 | $37.5M | Buy |
|
|||||
|
2016
Q3 | $39.8M | Buy |
|
|||||
|
2016
Q2 | $45.7M | Buy |
|
|||||
|
2016
Q1 | $44.2M | Buy |
|
|||||
|
2015
Q4 | $46.1M | Buy |
|
|||||
|
2015
Q3 | $35.8M | Sell |
|
|||||
|
2015
Q2 | $39.1M | Sell |
|
|||||
|
2015
Q1 | $40M | Buy |
|
|||||
|
2014
Q4 | $30.7M | Buy |
|
|||||
|
2014
Q3 | $32.6M | Buy |
|
|||||
|
2014
Q2 | $28.1M | Buy |
|
|||||
|
2014
Q1 | $27.2M | Sell |
|
|||||
|
2013
Q4 | $23.7M | Buy |
|
|||||
|
2013
Q3 | $15.5M | Buy |
|
|||||
|
2013
Q2 | $12.6M | Buy |
|